This is the authors' abstract. We don't add key points for this paper.
Psoriasis is a common chronic auto-inflammatory disease affecting 2% of the population worldwide 1. Recent research has indicated a possible pathophysiologic role of mammalian target of rapamycin (mTOR) pathway in psoriasis 2. The key pathological event in psoriasis is uncontrolled cellular proliferation of keratinocytes (KC), and mTOR has emerged as a major effector molecule of cell proliferation and differentiation 3. Psoralen plus ultraviolet A (PUVA) photochemotherapy is very effective treatment known to have strong antipsoriatic activity in psoriasis, although its therapeutic mechanism remains poorly understood 4. Recent studies from our laboratory showed that treatment of K5.hTGFβ1 transgenic (TG) mice with PUVA led to inhibition of the IL-23/Th17 axis, influenced chemokine and Th1/Th2/Th17 cytokine profile along with induction in Foxp3+ regulatory T cells and downregulated the pro-angiogenic cytokine IL-9 5. Furthermore, platelet-activating factor (PAF), a potent biolipid mediator possibly involved in psoriasis pathogenesis, was also shown to be effectively antagonized by PUVA in this mouse model 6. Since dysregulated cytokines and growth factors in auto-inflammatory diseases are known to activate mTOR signalling (S1), we investigated mTOR pathway functionality in the model. We asked whether PUVA affects mTOR pathway activation and its downstream component phospho-ribosomal protein S6 (pS6). All experiments were conducted using archived paraffin sections of murine tissues of wild-type control (WT) and untreated and PUVA-treated K5.hTGFβ1 transgenic (TG) skin from previously reported research by Singh et al. 5, 6. For additional details on materials and methods, see Data S1 and Table S1. Compared to WT controls, ribosomal phospho-S6 was highly upregulated in the entire epidermis of TG mice (Fig. 2d). However, in comparison with TG control, there was significant reduction by 62.5% in ribosomal phospho-S6 expression in PUVA-treated skin of TG mice (Fig. 2g,j) and the phospho-S6 protein was only expressed in the corneal layer similar to healthy control WT mouse skin (Fig. 2a). In contrast, the S6 protein staining was present throughout the epidermis of untreated skin of TG mice with approximately 35% reduction in PUVA-treated skin (Fig. 2e,h), while the S6 protein was significantly less expressed in normal skin of WT mice (Fig. 2b,k). Phospho-mTOR (at Ser2448), which is the active form of the protein, was expressed particularly in the stratum corneum and upper layers of the epidermis of both WT and TG mice (Fig. 1). There was a trend for increased expression in the epidermal basal layers of TG mice (Fig. 1c) compared with WT mice (Fig. 1a). However, the statistical analysis revealed that this difference was not significant (data not shown). Epidermal growth factor receptor (EGFR) staining expression and pattern (Fig. S1) paralleled the expression of pS6, suggesting similar protein levels (Fig. 2a,d,g). This study provides evidence that PUVA significantly downregulates pS6 (Ser235/236), a downstream component for mTOR activity in the K5.hTGFβ1 mouse model (Fig. 2). Even though psoriasis is an inflammatory disease, its pathology has ample resemblance to cancer entities, such as epidermal tumors in which the PI3-K/mTOR cascade is dysregulated (S2-S4). In psoriasis, critical function of the mTOR cascade is to integrate growth factors and cytokine-induced mitogenic signals into regulating epidermal growth and proliferation (2, S1). Thus, activation of these proteins, which are important in protein translation, reflects the need of KC to synthesize them. Furthermore, we confirmed that EGFR (Fig. S1), a subfamily receptor of tyrosine kinases lying upstream of PI3-K/mTOR cascade, was highly expressed in the diseased skin of TG mice, presumably due to dysregulated cytokines and its ligands contributing to the pathogenesis of psoriasis (S5-S7). Over the past few years, it has also become increasingly apparent that decreased Foxp3 expression is paired with constitutive overactivation of Akt/mTOR pathway in psoriatic lesions, (S8-9). This goes in accordance with our previous finding that PUVA significantly induced Foxp3+ regulatory T (Treg) cells in the lymph nodes and skin of K5.hTGFβ1 mice 5 as we observed in the present study that PUVA downregulated pS6. Indeed, the downregulation of Th17 and the induction of local Treg function in the skin of psoriasis patients appear to be crucial for the efficacy of an antipsoriatic treatment 7, 8. Furthermore, Singh et al. observed increased expression of CD62L and CCR7 in lymph nodes of PUVA-exposed animals, indicating the increased migration and homing of CD4+ T cells (5, S10). This is consistent with the observation that mTOR can prevent CD62L and CCR7 downregulation under certain circumstances. We also observed that mTOR was activated in WT and TG mice, regardless of PUVA treatment, while pS6 was found only in untreated skin of TG mice. This observation is consistent with the results presented by Buerger et al. 3 highlighting that mTOR activation is an early event while S6 activity is needed to sustain psoriasis. Thus, the present finding of normalization of pS6 expression in the mTOR pathway highlights the diverse immunoregulatory function of PUVA. Even though our study used only murine tissues (S11), the results could shed new light on PUVA's anti-inflammatory mechanism(s) affecting the mTOR pathway analogously to rapamycin 9 (S8, S12). Adding to the upcoming active research in KC biology, particularly in intracellular signalling 2 our study also testifies and provides new insight on the mTOR pathway as potential therapeutic target in psoriasis. Nonetheless, how PUVA downregulates pS6 without affecting mTOR itself needs to be determined. Regardless of the mechanism(s) involved, analysis of skin biopsies for site-specific S6 phosphorylation may be a useful criterion to assess the pharmacodynamics and efficacy of any antipsoriatic therapy in clinical trials. NS conceived the hypothesis; PW and NS designed the experiments; GM and NS performed the research; TPS generated the samples; NS and PW analysed, interpreted the data and wrote the paper; all authors revised and approved the final manuscript version. This project was supported by the Austrian Science Fund (FWF) project no. W1241-B18. NS was supported through the PhD program of Medical University of Graz. The authors thank H.N. Ananthaswamy (Houston, TX, USA) for critical reading of the manuscript. The authors have declared no conflicting interests. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Shirsath et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: